0001209191-18-041385.txt : 20180703
0001209191-18-041385.hdr.sgml : 20180703
20180703210322
ACCESSION NUMBER: 0001209191-18-041385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOFFMAN ROBERT
CENTRAL INDEX KEY: 0001166288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 18939323
MAIL ADDRESS:
STREET 1: ARENA PHARMACEUTICALS INC
STREET 2: 6166 NANCY RIDER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 6503662626
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-02
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001166288
HOFFMAN ROBERT
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
CFO & SVP, Finance
Common Stock
2018-04-30
5
J
0
E
744
13.2175
A
1280
D
Common Stock
2018-07-02
4
M
0
30000
15.30
A
31280
D
Common Stock
2018-07-02
4
S
0
28940
38.1516
D
2340
D
Common Stock
2018-07-02
4
S
0
1060
38.7953
D
1280
D
Employee Stock Option (Right to Buy)
15.30
2018-07-02
4
M
0
30000
0.00
D
2027-04-24
Common Stock
30000
100000
D
Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2018.
The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018.
The range of sales prices received was $37.60 to $38.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The range of sales prices received was $38.625 to $38.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Options vest and become exercisable with respect to 32,500 shares on the first anniversary of his first day of employment (the "Grant Date"), followed by 97,500 shares vesting ratably each month over the subsequent three years, such that 130,000 options will be fully vested on the four year anniversary of the Grant Date.
/s/ Robert E. Hoffman
2018-07-03